Zhu, Shiming <br/><br/>
Transforming growth factor-beta1 is associated with kidney damage in patients with essential hypertension: renoprotective effect of ACE inhibitor and/or angiotensin II receptor blocker.  [electronic resource] 

 -  Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association  Sep 2008 
 - 2841-6 p.  digital 
<br/><br/> Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1460-2385 
<br/><br/><label>Standard No.: </label>10.1093/ndt/gfn159  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Inhalation<br/>Angiotensin II--blood<br/>Angiotensin II Type 1 Receptor Blockers--pharmacology<br/>Angiotensin-Converting Enzyme Inhibitors--pharmacology<br/>Benzazepines--pharmacology<br/>Double-Blind Method<br/>Female<br/>Humans<br/>Hypertension--blood<br/>Kidney--drug effects<br/>Kidney Diseases--drug therapy<br/>Male<br/>Middle Aged<br/>Prospective Studies<br/>Tetrazoles--pharmacology<br/>Transforming Growth Factor beta1<br/>Valine--analogs & derivatives<br/>Valsartan